JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for ACB-CLIN-CHEM-GEN Archives


ACB-CLIN-CHEM-GEN Archives

ACB-CLIN-CHEM-GEN Archives


ACB-CLIN-CHEM-GEN@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

ACB-CLIN-CHEM-GEN Home

ACB-CLIN-CHEM-GEN Home

ACB-CLIN-CHEM-GEN  2006

ACB-CLIN-CHEM-GEN 2006

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

Re: Direct Urinary Cortisol using new Bayer kit

From:

"Ballieux, B.E.P.B. (CKCL)" <[log in to unmask]>

Reply-To:

Ballieux, B.E.P.B. (CKCL)

Date:

Wed, 27 Sep 2006 12:28:52 +0200

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (112 lines)

When planning to switch from Abbott TDx to Roche E170 we found a shift
upwards in results, despite the fact, that serum cortisol was fully
comparable between both machines. This shift was dependent on the
extraction method and differed for each sample as well, illustrating the
huge problem of crossreactivity in immunoassays for urinary free
cortisol.
As yet, we have not switched to E170 and we are now aiming at
LC-tandemMS.

With regards,

Bart Ballieux

Dr. Ir. B.E.P.B. Ballieux
Clinical Biochemist
Leiden University Medical Centre
P.O. box 9600
2300 RC  Leiden
The Netherlands
t:  +3171-5262165
f:  +3171-5266753
e:  [log in to unmask]



-----Original Message-----
From: Clinical biochemistry discussion list
[mailto:[log in to unmask]] On Behalf Of Brian Shine
Sent: dinsdag 26 september 2006 19:23
To: [log in to unmask]
Subject: Re: Direct Urinary Cortisol using new Bayer kit

We are in a similar fix, and have not been reporting any numbers.  We
were getting a bias of about 100 % on extracted urines.  At present, we
are reporting any that are below 280 nmol/day as normal, any above 560
as raised, and scratching our heads about those in between (or sending
them to a lab whose results we think we can believe).  In the medium
term, I guess we will look for another immunoassay, but in the long term
I think the only solution is a chromatographic method (there's a nice
report in the Annals this month).

Best wishes,
Brian Shine


> Can anybody using the new Enhanced Bayer cortisol kit for URINARY 
> CORTISOL let us know how whether they are reporting patient samples 
> with it. We find over recovery by about 300% against the previous kit.

> We reported this to Bayer verbally in June and sent a copy of our
comparison in July.
> Bayer were to take it up with the US, but to date no information has 
> been received.
> What are the users of the previous Bayer Cortisol kit for urinary 
> Cortisol doing, as the old kit is not available. We were aware with 
> problems of variable recovery with the old kit. We are not using an
extraction method.
> We are in the NEQAS, and Jonathan Middle has recently sent around a 
> questionnaire. The DPC and Roche methods listed are both extraction 
> methods, so maybe it is naive to hope we could use a direct assay.
> However, the CVs for the three methods listed are pretty poor.
> How have other laboratories solved their problems when urinary 
> Cortisol is requested?
>   
> ----------------------------------------------------------------------
> --------------------
>
> Dr Helen Grimes, Dept Clinical Biochemistry, University College 
> Hospital, Galway, Ireland
>
>
> The information contained in this email and in any attachments is 
> confidential and is designated solely for the attention and use of the

> intended recipient(s).
>
> If you are not the intended recipient of this e-mail, you should not 
> use,disclose, copy, distribute or retain this message or any part of 
> it. If you have received this in error, please notify me immediately 
> and delete all copies of this email from your computer system(s).
>
> This email has been processed by an automated anti-virus system; 
> however it is the responsibility of the recipient to ensure that the 
> message(and attachments)is safe and authorized for use in their own 
> environment.

------ACB discussion List Information-------- This is an open discussion
list for the academic and clinical community working in clinical
biochemistry.
Please note, archived messages are public and can be viewed via the
internet. Views expressed are those of the individual and they are
responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/

------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
2006
2005
2004
2003
2002
2001
2000
1999
1998


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager